Revenue Update on BIOLASE Inc(NASDAQ:BIOL)

BIOLASE Inc(NASDAQ:BIOL) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 1, 2016. Company reported revenue of $13.81M. Analysts estimated a revenue of $12.90M. Earnings per share were $-0.04. Analysts had estimated an EPS of $-0.03.

BIOLASE Inc (BIOL) made into the market gainers list on Mondays trading session with the shares advancing 9.45% or 0.12 points. Due to strong positive momentum, the stock ended at $1.39, which is also near the day’s high of $1.45. The stock began the session at $1.28 and the volume stood at 2,08,953 shares. The 52-week high of the shares is $1.72 and the 52 week low is $0.6. The company has a current market capitalization of $81 M and it has 5,82,57,301 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Dec 18, 2015, Jack W Schuler (10% owner) purchased 3,296,237 shares at $0.91 per share price.Also, On Nov 12, 2015, Jonathan T Md Lord (director) purchased 16,310 shares at $0.75 per share price.On Nov 12, 2015, Paul N Clark (director) purchased 134,579 shares at $0.76 per share price, according to the Form-4 filing with the securities and exchange commission.

BIOLASE Inc. (BIOLASE) is a medical device company that develops manufactures markets and sells laser systems in dentistry and medicine. The Company markets sells and distributes dental imaging equipment including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners in-office chair-side milling machines and three-dimensional (3-D) printers. The Company’s dental laser systems allow dentists periodontists endodontists oral surgeons and other dental specialists to perform a range of minimally invasive dental procedures including cosmetic restorative and complex surgical applications. Combining its laser system products with imaging solutions provides dental professionals capabilities for early diagnosis and minimally invasive treatment. It markets and sells its laser systems in the United States Canada the European Union and other countries outside the United States.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

BIOLASE Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on BIOLASE Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.